ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $263,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $41,468,000 | 7.46% |
| BVF INC/IL | 991,433 | $22,347,000 | 3.81% |
| Iguana Healthcare Management, LLC | 400,000 | $9,016,000 | 2.97% |
| APEX CAPITAL, LLC | 382,000 | $8,610,000 | 0.92% |
| Birchview Capital, LP | 58,689 | $1,323,000 | 0.76% |
| BRAVE ASSET MANAGEMENT INC | 46,550 | $1,049,000 | 0.71% |
| HAMILTON LANE ADVISORS LLC | 44,376 | $1,000,000 | 0.44% |
| NJ State Employees Deferred Compensation Plan | 70,000 | $1,578,000 | 0.32% |
| Eventide Asset Management | 190,000 | $4,283,000 | 0.21% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 308,600 | $6,956,000 | 0.18% |